These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34761455)

  • 1. Structure-activity relationship studies of allosteric inhibitors of EYA2 tyrosine phosphatase.
    Anantharajan J; Baburajendran N; Lin G; Loh YY; Xu W; Ahmad NHB; Liu S; Jansson AE; Kuan JWL; Ng EY; Yeo YK; Hung AW; Joy J; Hill J; Ford HL; Zhao R; Keller TH; Kang C
    Protein Sci; 2022 Feb; 31(2):422-431. PubMed ID: 34761455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells.
    Anantharajan J; Zhou H; Zhang L; Hotz T; Vincent MY; Blevins MA; Jansson AE; Kuan JWL; Ng EY; Yeo YK; Baburajendran N; Lin G; Hung AW; Joy J; Patnaik S; Marugan J; Rudra P; Ghosh D; Hill J; Keller TH; Zhao R; Ford HL; Kang C
    Mol Cancer Ther; 2019 Sep; 18(9):1484-1496. PubMed ID: 31285279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.
    Krueger AB; Drasin DJ; Lea WA; Patrick AN; Patnaik S; Backos DS; Matheson CJ; Hu X; Barnaeva E; Holliday MJ; Blevins MA; Robin TP; Eisenmesser EZ; Ferrer M; Simeonov A; Southall N; Reigan P; Marugan J; Ford HL; Zhao R
    J Biol Chem; 2014 Jun; 289(23):16349-61. PubMed ID: 24755226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity.
    Krueger AB; Dehdashti SJ; Southall N; Marugan JJ; Ferrer M; Li X; Ford HL; Zheng W; Zhao R
    J Biomol Screen; 2013 Jan; 18(1):85-96. PubMed ID: 22820394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based de novo design of Eya2 phosphatase inhibitors.
    Park H; Ryu SE; Kim SJ
    J Mol Graph Model; 2012 Sep; 38():382-8. PubMed ID: 23085179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based virtual screening approach to the discovery of novel inhibitors of eyes absent 2 phosphatase with various metal chelating moieties.
    Park H; Jung SK; Yu KR; Kim JH; Kim YS; Ko JH; Park BC; Kim SJ
    Chem Biol Drug Des; 2011 Oct; 78(4):642-50. PubMed ID: 21777393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of ED-Eya2: insight into dual roles as a protein tyrosine phosphatase and a transcription factor.
    Jung SK; Jeong DG; Chung SJ; Kim JH; Park BC; Tonks NK; Ryu SE; Kim SJ
    FASEB J; 2010 Feb; 24(2):560-9. PubMed ID: 19858093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.
    Tadjuidje E; Wang TS; Pandey RN; Sumanas S; Lang RA; Hegde RS
    PLoS One; 2012; 7(4):e34806. PubMed ID: 22545090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers.
    Gardner L; Rossi J; Armstrong B; Muse M; LaVeck A; Blevins MA; Zhang L; Ford HL; Zhao R; Wang X
    ChemMedChem; 2024 Sep; 19(18):e202400179. PubMed ID: 38861151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Eyes Absent Proteins: Unusual HAD Family Tyrosine Phosphatases.
    Roychoudhury K; Hegde RS
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis.
    Zhou H; Blevins MA; Hsu JY; Kong D; Galbraith MD; Goodspeed A; Culp-Hill R; Oliphant MUJ; Ramirez D; Zhang L; Trinidad-Pineiro J; Mathews Griner L; King R; Barnaeva E; Hu X; Southall NT; Ferrer M; Gustafson DL; Regan DP; D'Alessandro A; Costello JC; Patnaik S; Marugan J; Zhao R; Ford HL
    Cancer Res; 2020 Jun; 80(12):2689-2702. PubMed ID: 32341035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome.
    Patrick AN; Cabrera JH; Smith AL; Chen XS; Ford HL; Zhao R
    Nat Struct Mol Biol; 2013 Apr; 20(4):447-53. PubMed ID: 23435380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Phosphatase Assays for the Eya2 Tyrosine Phosphatase.
    Alderman C; Krueger A; Rossi J; Ford HL; Zhao R
    Methods Mol Biol; 2024; 2743():285-300. PubMed ID: 38147222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eya2 is critical for the E2A‑HLF‑mediated immortalization of mouse hematopoietic stem/progenitor cells.
    Maharjan BD; Ono R; Nosaka T
    Int J Oncol; 2019 Mar; 54(3):981-990. PubMed ID: 30628662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent.
    Krishnan N; Jeong DG; Jung SK; Ryu SE; Xiao A; Allis CD; Kim SJ; Tonks NK
    J Biol Chem; 2009 Jun; 284(24):16066-16070. PubMed ID: 19351884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.
    Vincent A; Hong SM; Hu C; Omura N; Young A; Kim H; Yu J; Knight S; Ayars M; Griffith M; Van Seuningen I; Maitra A; Goggins M
    Oncotarget; 2014 May; 5(9):2575-87. PubMed ID: 24810906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastrophe.
    Zhang G; Dong Z; Gimple RC; Wolin A; Wu Q; Qiu Z; Wood LM; Shen JZ; Jiang L; Zhao L; Lv D; Prager BC; Kim LJY; Wang X; Zhang L; Anderson RL; Moore JK; Bao S; Keller TH; Lin G; Kang C; Hamerlik P; Zhao R; Ford HL; Rich JN
    J Exp Med; 2021 Nov; 218(11):. PubMed ID: 34617969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing biological mechanisms with chemical tools.
    Kang C; Keller TH
    Pharmacol Res; 2020 Mar; 153():104656. PubMed ID: 31962154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
    Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
    Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal signaling between the transcriptional co-factor Eya2 and specific members of the Galphai family.
    Embry AC; Glick JL; Linder ME; Casey PJ
    Mol Pharmacol; 2004 Nov; 66(5):1325-31. PubMed ID: 15308761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.